Breakthrough Therapies NTRK With Robert Doebele
from Lung Cancer Considered Hosted by IASLC
In this episode of Lung Cancer Considered, host Dr. Narjust Duma talks with Dr. Robert C. Doebele, Co-Founder and Chief Scientific Officer, Rain Therapeutics about NTKR gene fusions, including recent and emerging breakthrough therapies.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of Lung Cancer Considered?
This episode is 32 minutes long.
When was this Lung Cancer Considered episode published?
This episode was published on March 15, 2022.
Can I download this Lung Cancer Considered episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.